Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
Emilya Huseynova, Principal Scientist in Clinical Research at The American Red Cross, shared on LinkedIn:
”I am excited to share that my work on blood safety monitoring has just been published by Transfusion.
This research became possible because of the hard work of my science team at the Transfusion Safety and Surveillance, American Red Cross and our collaborators at Vitalant, OneBlood, New York Blood Center, and the FDA.
Our continuous national monitoring of the safety of blood donations shows that expanded donor eligibility due to updated FDA guidance from 12-month deferral to 3-month deferral for certain high-risk behaviors has not negatively impacted the prevalence of the major transfusion-transmissible infections in the US blood.
We continue our critical work to gather data and to evaluate the newest updates to donor deferral policy by FDA based on individualized donor assessment that became effective in 2023, to ensure the safety of our blood donations for our transfusion patients.
You can read more about our work here.”
Read the full article here.
Article: Prevalence of HIV, HBV, and HCV in United States blood donations, 2015–2023: The transfusion-transmissible infections monitoring system (TTIMS)
Authors: Emilya Huseynova, James Haynes, Edward P. Notari, Brian Custer, Rita Reik, Jed Gorlin, Artur Belov, Hong Yang, Roger Y. Dodd, Susan L. Stramer

Stay updated on all scientific advances in the field of Transfusion Medicine with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
